OBJECTIVES: Human evidence of carcinogenicity concerning shift work is inconsistent. In a previous study, we observed no elevated risk of total mortality in shift workers followed up until the end of 2006. The present study aimed to investigate cancer-specific mortality, relative to shift work. METHODS: The cohort consisted of male production workers (14,038 shift work and 17,105 day work), employed at BASF Ludwigshafen for at least 1 year between 1995 and 2005. Vital status was followed from 2000 to 2009. Cause-specific mortality was obtained from death certificates. Exposure to shift work was measured both as a dichotomous and continuous variable. While lifetime job history was not available, job duration in the company was derived from personal data, which was then categorized at the quartiles. Cox proportional hazard model was used to adjust for potential confounders, in which job duration was treated as a time-dependent covariate. RESULTS: Between 2000 and 2009, there were 513 and 549 deaths among rotating shift and day work employees, respectively. Risks of total and cancer-specific mortalities were marginally lower among shift workers when taking age at entry and job level into consideration and were statistically significantly lower when cigarette smoking, alcohol intake, job duration, and chronic disease prevalence at entry to follow-up were included as explanatory factors. With respect to mortality risks in relation to exposure duration, no increased risks were found in any of the exposure groups after full adjustment and there was no apparent trend suggesting an exposure-response relation with duration of shift work. CONCLUSIONS: The present analysis extends and confirms our previous finding of no excess risk of mortality associated with work in the shift system employed at BASF Ludwigshafen. More specifically, there is also no indication of an increased risk of mortality due to cancer.
OBJECTIVES:Human evidence of carcinogenicity concerning shift work is inconsistent. In a previous study, we observed no elevated risk of total mortality in shift workers followed up until the end of 2006. The present study aimed to investigate cancer-specific mortality, relative to shift work. METHODS: The cohort consisted of male production workers (14,038 shift work and 17,105 day work), employed at BASF Ludwigshafen for at least 1 year between 1995 and 2005. Vital status was followed from 2000 to 2009. Cause-specific mortality was obtained from death certificates. Exposure to shift work was measured both as a dichotomous and continuous variable. While lifetime job history was not available, job duration in the company was derived from personal data, which was then categorized at the quartiles. Cox proportional hazard model was used to adjust for potential confounders, in which job duration was treated as a time-dependent covariate. RESULTS: Between 2000 and 2009, there were 513 and 549 deaths among rotating shift and day work employees, respectively. Risks of total and cancer-specific mortalities were marginally lower among shift workers when taking age at entry and job level into consideration and were statistically significantly lower when cigarette smoking, alcohol intake, job duration, and chronic disease prevalence at entry to follow-up were included as explanatory factors. With respect to mortality risks in relation to exposure duration, no increased risks were found in any of the exposure groups after full adjustment and there was no apparent trend suggesting an exposure-response relation with duration of shift work. CONCLUSIONS: The present analysis extends and confirms our previous finding of no excess risk of mortality associated with work in the shift system employed at BASF Ludwigshafen. More specifically, there is also no indication of an increased risk of mortality due to cancer.
Authors: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen Journal: N Engl J Med Date: 2012-03-15 Impact factor: 91.245
Authors: Sara Villeneuve; Joëlle Févotte; Antoinette Anger; Thérèse Truong; Farida Lamkarkach; Oumar Gaye; Pierre Kerbrat; Patrick Arveux; Laurent Miglianico; Ellen Imbernon; Pascal Guénel Journal: Am J Ind Med Date: 2011-04-06 Impact factor: 2.214
Authors: Ashwin N Ananthakrishnan; Hamed Khalili; Gauree G Konijeti; Leslie M Higuchi; Punyanganie de Silva; Charles S Fuchs; James M Richter; Eva S Schernhammer; Andrew T Chan Journal: Clin Gastroenterol Hepatol Date: 2014-04-26 Impact factor: 11.382
Authors: Fangyi Gu; Jiali Han; Francine Laden; An Pan; Neil E Caporaso; Meir J Stampfer; Ichiro Kawachi; Kathryn M Rexrode; Walter C Willett; Susan E Hankinson; Frank E Speizer; Eva S Schernhammer Journal: Am J Prev Med Date: 2015-01-06 Impact factor: 5.043
Authors: Mei Yong; Michael Nasterlack; Christina Germann; Stefan Lang; Christoph Oberlinner Journal: Int Arch Occup Environ Health Date: 2013-12-03 Impact factor: 3.015
Authors: Gaël P Hammer; Katharina Emrich; Michael Nasterlack; Maria Blettner; Mei Yong Journal: Dtsch Arztebl Int Date: 2015-07-06 Impact factor: 5.594
Authors: Harald Hannerz; Helle Soll-Johanning; Ann Dyreborg Larsen; Anne Helene Garde Journal: Int Arch Occup Environ Health Date: 2018-12-04 Impact factor: 3.015